Advertisement

Case of a Girl with Obesity Seeking Birth Control

Abstract

There are several issues to consider when choosing a contraceptive method for an adolescent girl with obesity. When prescribing hormonal contraception, it is important to bear in mind that there is an increased risk for cardiovascular disease, diabetes, and other obesity-related comorbidities in addition to the increased risks associated with persisting obesity in adulthood. There is also evidence that increasing obesity may decrease the efficacy of some contraceptive modalities. Further, despite higher risks for pregnancy-related complications, overweight or obese females have been shown to be less likely to use contraception than their normal-weight peers. An inability to negotiate contraceptive use with a partner and provider inexperience with prescribing contraception are areas that need to be explored and addressed with such patients. Counseling related to effective emergency contraception is important especially if patients have concerns related to negotiating contraceptive use. A final consideration relates to the importance of providing effective contraception for obese adolescents who are contemplating bariatric surgery and require long-term effective contraception.

Keywords

Obesity Contraception Efficacy Adolescent Medically complex 

References

  1. 1.
    Ogden CL, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549–55.CrossRefGoogle Scholar
  2. 2.
    Skinner A, Skelton JA. Prevalence and trends in obesity and severe obesity among children in the United States, 1999-2012. JAMA Pediatr. 2014. https://doi.org/10.1001/jamapediatrics.2014.21.
  3. 3.
    Chang T, et al. Sexual behavior and contraceptive use among 18-19-year-old adolescent women by weight status: a longitudinal analysis. J Pediatr. 2015;167:586–92.CrossRefGoogle Scholar
  4. 4.
    Lopez LM, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2013;(4):CD008452.Google Scholar
  5. 5.
    WHO medical eligibility for contraceptive use. 5th ed. Available at http://apps.who.int/iris/bitstream/10665/181468/1/9789241549158_eng.pdf?ua=1. Accessed on 07/10/2016.
  6. 6.
    Centers for Disease Control and Prevention (CDC). U.S. medical eligibility criteria for contraceptive use. MMWR Recomm Rep. 2010;59(RR04):1–6.Google Scholar
  7. 7.
    Bonny AE, et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med. 2006;160(1):40–5.CrossRefGoogle Scholar
  8. 8.
    Gallo MF, et al. Combination contraceptives; effects on weight. Cochrane Database Syst Rev. 2014;(1):CD003987.Google Scholar
  9. 9.
    Greydanus DE, et al (2009). Concepts of Contraception for adolescents with obesity: pathways of judicial moderation. pediatrics faculty publications. Paper 137. Available at: http://uknowledge.uky.edu/pediatrics_facpub/137. Accessed on 7/10/2016.
  10. 10.
    Westhoff C, et al. Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception. 2010;81(6):474.CrossRefGoogle Scholar
  11. 11.
    Dinger J, et al. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol. 2011;117(1):33.CrossRefGoogle Scholar
  12. 12.
    Zieman M, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. 2002;77(2 Suppl 2):S13.CrossRefGoogle Scholar
  13. 13.
    Dragoman M, et al. Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women. Contraception. 2013;87(4):432–6. Epub 2012 Dec 10.CrossRefGoogle Scholar
  14. 14.
    Xu H, et al. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol. 2012;120(1):21.CrossRefGoogle Scholar
  15. 15.
    Mornar S, et al. Pharmacokinetics of the etonogestrel contraceptive implant in obese women. Obstet Gynecol. 2012;207(2):110.e1.Google Scholar
  16. 16.
    Segall-Gutierrez P, et al. Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously. Contraception. 2010;81(6):487.CrossRefGoogle Scholar
  17. 17.
    Griffiths LJ, et al. Self-esteem and quality of life in obese children and adolescents: a systematic review. Int J Pediatr Obes. 2010;5:282–304.CrossRefGoogle Scholar
  18. 18.
    Ethier KA, et al. Self-esteem, emotional distress and sexual behavior among adolescent females: inter-relationships and temporal effects. J Adolesc Health. 2006;38(3):268–74.CrossRefGoogle Scholar
  19. 19.
    Alexander SC, et al. Sexuality talk during adolescent health maintenance visits. JAMA Pediatr. 2014;168:163–9.CrossRefGoogle Scholar
  20. 20.
    O’Brien SH, et al. Identification, evaluation, and management of obesity in an academic primary care center. Pediatrics. 2004;114:e154–9.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Division of Adolescent Medicine, The Pediatric Hospital for Albert Einstein College of MedicineChildren’s Hospital at MontefioreBronxUSA
  2. 2.Department of Pediatrics, The Pediatric Hospital for Albert Einstein College of MedicineChildren’s Hospital at MontefioreBronxUSA
  3. 3.Division of Hospital Medicine, The Pediatric Hospital for Albert Einstein College of MedicineChildren’s Hospital at MontefioreBronxUSA

Personalised recommendations